Study Title
B0661037: A randomised and open-label and active controlled and safety and extrapolated efficacy study in paediatric subjects requiring anticoagulation for the treatment of a venous thromboembolic event (Phase IV) Apixaban
Protocol ID
B0661037
Condition/s
Venous Thromboembolism
Diagnosis Stage
New Diagnosis
Relapse/Refractory
Relapse/Refractory
Location
NSW
Sponsor
Pfizer
Collaborators
Bristol-Myers Squibb
Links
Trial Status
Closed to Recruitment
Sites
Sydney Children's Hospital
Study Type
Treatment
Phase
Phase 4
Age Eligibility
3 Months to 17 Years
International registry ID's
NCT02464969
| Study Title | B0661037: A randomised and open-label and active controlled and safety and extrapolated efficacy study in paediatric subjects requiring anticoagulation for the treatment of a venous thromboembolic event (Phase IV) Apixaban |
|---|---|
| Protocol ID | B0661037 |
| Disease (Sub Disease) | Venous Thromboembolism |
| Diagnosis Stage | New Diagnosis Relapse/Refractory |
| Location | NSW |
| Sponsor | Pfizer |
| Collaborators | Bristol-Myers Squibb |
| Links | https://clinicaltrials.gov/ct2/show/NCT02464969 |
| Trial Status | Closed to Recruitment |
| Trial Open Date | 02/08/2018 |
| Sites | Sydney Children's Hospital |
| Study Type | Treatment |
| Phase | Phase 4 |
| Age Eligibility | 3 Months to 17 Years |
| International registry ID's | NCT02464969 |